The caloric nystagmus of rhesus monkeys in the ‘optimum’ supine or prone position was recorded three-dimensionally using magnetic search coils. The horizontal component of the nystagmus was in the direction expected from the convection flow theory of Bárány. The torsional component changed its direction according to the side of caloric stimulation independent of head position with regard to gravity, i.e., counterclockwise nystagmus by right ear stimulation and clockwise nystagmus by left ear stimulation both in the supine or in the prone positions. The direction of the vertical component depended upon the head position and not upon the side of stimulation, i.e., up-beating nystagmus in the supine position and down-beating nystagmus in the prone position. The durations and the contours of slow phase velocity of the horizontal, vertical and torsional components were different from each other. The origins of the first phase of caloric nystagmus in three dimensions may be explained by activation of all the three semicircular canals. As for the second phase of caloric nystagmus in the supine or in the prone position, the torsional component was comparatively strong and lasted the longest among the three components. The second phase of caloric nystagmus was markedly modified by head position with regard to gravity. These findings suggest that it is the otolithic organs that determine the moving plane of second phase caloric nystagmus.

Keywords:
Caloric nystagmus, Canal-otolithic interaction, Three-dimensional eye recording, Rhesus monkey
This content is only available via PDF.
© 1990 S. Karger AG, Basel
1990
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.